Recombinant Human monoclonal antibody expressed in CHO binding to Human IL13RA1. The antibody antagonists which bind to human interleukin-13 receptor alpha 1 through domain 3 of the extracellular region of the receptor and inhibit IL-13 receptor-mediated signaling by IL-13. These antibodiess have uses inter alia in the treatment or prevention of IL-13-related disorders and diseases, such as allergic disorders and asthma.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-074ZJ | Anti-Human IL-13Rα1 Recombinant Antibody (LC5002-002) | ELISA, FC, Inhib | Human antibody |
TAB-074ZJ-S(P) | Anti-Human IL-13Rα1 Recombinant Antibody scFv Fragment (LC5002-002) | ELISA, FC, Inhib | Human antibody |
TAB-074ZJ-F(E) | Anti-Human IL-13Rα1 Recombinant Antibody Fab Fragment (LC5002-002) | ELISA, FC, Inhib | Human antibody |
There are currently no Customer reviews or questions for TAB-396CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.